The Role of P-Glycoprotein (P-gp) in Cancer Multidrug Resistance (MDR): Challenges for Inhibiting P-gp in the Context of Overcoming MDR
Journal of Pharmaceutical Research International · pp. 44–58 · Published 31 Aug 2023
10.9734/jpri/2023/v35i237422Abstract
Multidrug resistance (MDR), as is well known, is regarded as the primary factor in cancer therapy failure. A common mechanism of MDR in anticancer drugs is the expression of P-glycoprotein (P-gp), a class of ATP-dependent membrane transport efflux pumps called adenosine triphosphate (ATP)-binding cassette (ABC) transporters. It pumps xenobiotics outside the cell and plays part in typical physiological detoxification and host defense activities. This transporter is distributed in gastrointestinal mucosa epithelial cell surfaces, blood-tissue barriers, hepatic biliary epithelium, proximal tubules of the kidney, and the adrenal cortex. P-gp is known to be responsible for MDR because of its over-expression in malignant cells. It functions as an efflux pump lowering the concentration of drugs intracellularly, thus decreasing the effectiveness of cancer chemotherapy. Although using multiple anticancer medications is a good strategy, Cancerous cells are able to develop MDR. A number of chemically synthesized P-gp inhibitors were investigated to overcome MDR in clinical studies. Additionally, certain natural compounds have been observed to modulate P-gp. Numerous investigations on strategies to modulate MDR have been conducted as a result of the significant impact of chemotherapeutic drug resistance. This review discusses the role of P-gp in cancer MDR and challenges for inhibiting P-gp in the context of overcoming MDR mediated by P-gp. It is concluded that the discovery of selective, safe, and potent inhibitors of P-gp remains necessary.
Cited by 12
ARTHORN LOISRUANGSIN, SASIWADEE BOONYA-UDTAYAN, WEENAWAN SOMPHON · Asian Journal of Pharmaceutical and Clinical Research · 2025
Mansoureh Hoseini, Hossein Abbasi · 2025
Mihaela Lipovanu, Anca Miron, Nina Filip · Pharmaceuticals · 2026
Junaid Tantray, Soumi Das, Akhilesh Patel · Bladder Cancer Breakthroughs · 2026
Tanaka Ndongwe, Nathi Skosana, Bwalya Witika · International Journal of Nanomedicine · 2026
Zechariah Oluwapelumi Oresanya, Godswill Chimezirim Eleanya, Taiwo Abdulmaruf Akande · 2025
Zechariah Oluwapelumi Oresanya, Godswill Chimezirim Eleanya, Taiwo Abdulmaruf Akande · Discover Chemistry · 2026
· Journal of Biomedical Physics and Engineering · 2024
Chao Pan, Leo Tsz On Lee · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2025
Ronisha Shankar Rao, Ashok Kumar Pandurangan · Roles of Mitophagy in Cancer Regulation · 2025
Related research
- Stochastic Optimization Models for Cancer Chemotherapy — shares topic coverage
- Safety Profile and Toxicity Amelioration Strategies of Common Adverse Effects Associated with Anticancer Medications — shares topic coverage
- Emerging Trends in Quinolone Resistance among Urinary Pathogens: A Brief Review — shares topic coverage
- Bacterial Isolates and Drug Susceptibility Pattern of Sterile Body Fluids at a Tertiary Care Hospital in Northern India — shares topic coverage
- Synthesis of Eco-friendly Silver Nanoparticles (AgNPs) by Lacticaseibacillus rhamnosus for Combating Antibiotic Resistance and Boosting Antioxidant Activity — shares topic coverage
Article metrics
Real usage data collected on this platform.
5
Page views
0
PDF downloads
6
Outbound clicks
12
Citations
Views over time
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
Traffic sources
Referring site, by host.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.